ZA935918B - Anti-cancer therapeutic compositions for prophylais or for treatment of cancer - Google Patents

Anti-cancer therapeutic compositions for prophylais or for treatment of cancer

Info

Publication number
ZA935918B
ZA935918B ZA935918A ZA935918A ZA935918B ZA 935918 B ZA935918 B ZA 935918B ZA 935918 A ZA935918 A ZA 935918A ZA 935918 A ZA935918 A ZA 935918A ZA 935918 B ZA935918 B ZA 935918B
Authority
ZA
South Africa
Prior art keywords
cancer
treatment
prophylais
therapeutic compositions
cancer therapeutic
Prior art date
Application number
ZA935918A
Other languages
English (en)
Inventor
Gustavo Bounous
Phil Gold
Original Assignee
Immunotec Res Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotec Res Corp Ltd filed Critical Immunotec Res Corp Ltd
Publication of ZA935918B publication Critical patent/ZA935918B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Steroid Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA935918A 1992-08-13 1993-08-13 Anti-cancer therapeutic compositions for prophylais or for treatment of cancer ZA935918B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92934792A 1992-08-13 1992-08-13

Publications (1)

Publication Number Publication Date
ZA935918B true ZA935918B (en) 1994-03-09

Family

ID=25457715

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935918A ZA935918B (en) 1992-08-13 1993-08-13 Anti-cancer therapeutic compositions for prophylais or for treatment of cancer

Country Status (15)

Country Link
EP (1) EP0655925B1 (es)
JP (2) JP4115515B2 (es)
KR (1) KR100297610B1 (es)
CN (1) CN1088095A (es)
AT (1) ATE265217T1 (es)
AU (1) AU687356B2 (es)
CA (1) CA2142277C (es)
CZ (1) CZ295849B6 (es)
DE (1) DE69333497T2 (es)
IL (1) IL106576A (es)
MX (1) MX9304925A (es)
NZ (1) NZ254704A (es)
TW (1) TW380051B (es)
WO (1) WO1994004168A1 (es)
ZA (1) ZA935918B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
TWI438675B (zh) 2010-04-30 2014-05-21 Ibm 提供情境感知援助說明之方法、裝置及電腦程式產品
CN102232556A (zh) * 2010-04-30 2011-11-09 李德远 一种抗偏二甲肼的食品添加剂
WO2013086459A1 (en) * 2011-12-07 2013-06-13 Arla Foods Amba Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants
DE102014001037A1 (de) * 2014-01-25 2015-07-30 Gea Tds Gmbh Verfahren und Vorrichtung zur Reduzierung des Wachstums thermophiler Keime in Magermilch
CN104146269B (zh) * 2014-07-28 2015-08-19 苏喜生 一种用于抗偏二甲肼的应激食品添加剂及其制备方法
CN105831769A (zh) * 2015-02-04 2016-08-10 张亚武 一种细胞内/细胞间对癌症抑制之食物
WO2018057514A1 (en) 2016-09-23 2018-03-29 Immunotec Inc. Compositions for restoring gene expression in neuropsychiatric or neurodegenerative disorders
CA2970699A1 (en) 2017-06-14 2018-12-14 Elizabeth E. Ignowski Compositions for increasing resilience to traumatic brain injury
WO2019027974A1 (en) 2017-07-31 2019-02-07 Immunotec Inc. COMPOSITIONS AND METHODS FOR TREATING AUTISM SPECTRUM DISORDER

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628010A1 (de) * 1986-08-19 1988-02-25 Astra Chem Gmbh Arzneimittel fuer die verwendung bei der behandlung von hypertonie
DE3870247D1 (de) * 1988-12-21 1992-05-21 Siemens Ag Schienenfahrzeug.
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
JPH03216156A (ja) * 1990-01-22 1991-09-24 Gustavo Bounous 生物学的に活性なホエータンパク質組成物、その製法および組成物の使用法

Also Published As

Publication number Publication date
EP0655925A1 (en) 1995-06-07
AU687356B2 (en) 1998-02-26
NZ254704A (en) 1997-08-22
CN1088095A (zh) 1994-06-22
ATE265217T1 (de) 2004-05-15
IL106576A0 (en) 1993-12-08
CZ28395A3 (en) 1995-10-18
MX9304925A (es) 1994-08-31
JP4115515B2 (ja) 2008-07-09
DE69333497T2 (de) 2005-01-13
EP0655925B1 (en) 2004-04-28
IL106576A (en) 2000-08-13
JPH08500108A (ja) 1996-01-09
AU4693793A (en) 1994-03-15
DE69333497D1 (de) 2004-06-03
KR950702837A (ko) 1995-08-23
CA2142277C (en) 2000-01-18
TW380051B (en) 2000-01-21
WO1994004168A1 (en) 1994-03-03
CZ295849B6 (cs) 2005-11-16
CA2142277A1 (en) 1994-03-03
JP2008115194A (ja) 2008-05-22
KR100297610B1 (ko) 2001-10-24

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
AU4515985A (en) New tetrapyrrole therapeutic agents
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
MX9702932A (es) L-ribofuranosilnucleosidos.
AU4835693A (en) Pharmaceutical composition comprising phosphatase or a derivative thereof
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
ZA935918B (en) Anti-cancer therapeutic compositions for prophylais or for treatment of cancer
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
GR3006815T3 (es)
EP0347899A3 (en) Pharmaceutical compositions on egg shell basis and their preparation and use
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
DE3584775D1 (de) Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken.
EP0699444A3 (en) Composition for the treatment of intestinal wounds or ulcers containing proteins, carbohydrates and fat
MX9702926A (es) L-eritrosilnucleosidos.
BE900012A (fr) Nouveau peptide.
CA2100720A1 (en) Medicinal composition comprising tcf-ii
GB9516967D0 (en) Pharmaceutical composition
MX9702927A (es) L-piranosilnucleosidos.
DE3374066D1 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
ES2158776A1 (es) Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.
MX9700929A (es) Metodos y composiciones utiles en la profilaxis y terapia de condiciones relacionadas a la endotoxina.